Principaux résultats et analyse des parts de marché de la pharmacovigilance d'ici 2025-2031
Pharmacovigilance Market Report Analysis
Pharmacovigilance Market
-
CAGR (2025 - 2031)6.6% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Accenture
- Bristol-Myers Squibb Company
- Linical Accelovance
- Cognizant
- Covance Inc.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc.
- ICON plc
- Capgemini (IGATE Corporation)
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Phase d'essai clinique
- préclinique
- phase I
- phase II
- phase III
- phase IV
By Fournisseur de services
- interne et externalisation sous contrat
By Type de méthode
- déclaration spontanée
- déclaration intensive des effets indésirables
- déclaration spontanée ciblée
- surveillance des événements de cohorte
- exploration des DSE
By Utilisateur final
- hôpitaux
- organismes de recherche
- sociétés pharmaceutiques et biotechnologiques
Get Free Sample For